exocad GmbH (exocad), an Align Technology, Inc. company, today announced the release of PartialCAD 3.0 Galway, its module for removable partial denture frameworks, with new and advanced features for the design of high-quality partial dentures. This new release enhances digital CAD/CAM possibilities for exocad users and dental technicians by providing simpler design solutions for complex cases. PartialCAD 3.0 Galway provides both experts and new users with smooth, improved integration with DentalCAD, exocad’s leading software for dental laboratories.

“With PartialCAD 3.0 Galway, we give dental experts more flexibility in their design workflow,” said Tillmann Steinbrecher, CEO and cofounder of exocad. “Custom partial dentures can be created and used quickly, helping those who require or request partials to smile brighter and improve their quality of life.”

The PartialCAD 3.0 Galway release includes a range of new tools and benefits that empower dental professionals through more design freedom.

Highlights of the new module include:

• Accurate fits from attachment-based partial framework designs without needing to scan the attachment itself or the accessory parts

• Smooth interaction of the crown-and-bridge workflow and partial-framework workflow allows comfortable reverse planning of the whole restoration

• Integration of partial framework design with DentalCAD enables the design of multiple separate elements like framework, teeth and gingiva

• Reverse planning with exportable teeth and gingiva and the possibility to seamlessly combine secondary telescopic crowns with partial frameworks

PartialCAD 3.0 Galway is available immediately worldwide as an add-on module or standalone module and can be accessed by all users with a valid upgrade contract. exocad names its releases after current “European Capitals of Culture” and selected the Irish city of Galway for this release.

Additional information is available at exocad.com/partialcad

Today, the Delta Dental Institute released its 2020 Community Impact Report, highlighting the investments the Delta Dental companies and their foundations made in 2020 to advance oral health, respond to COVID-19, and address health inequities and disparities. Delta Dental invested more than $102.5 million in communities in 2020, supporting over 2,400 programs, impacting 24.7 million lives, and volunteering 20,000 hours—more than ever before in Delta Dental’s 65-year history. In addition to their community impact engagement, Delta Dental companies across the country also committed $1.1 billion in COVID-19 response relief.

"As our country grappled with a pandemic, injustice, and lingering gaps in oral health care access and education, Delta Dental stood with our communities to meet their most pressing needs," said James W. Hutchison, President & CEO, Delta Dental Plans Association. "In a time of crisis and uncertainty, Delta Dental never wavered in its enduring commitment to achieve access and equity for all."

The 2020 Community Impact Report, "Our Promise to Our Communities," centers on Delta Dental's mission to advance the oral and overall health of its communities. Last year, Delta Dental supported programs in all 50 states, Washington, D.C., and Puerto Rico.

The report highlights three main areas of giving in 2020: advancing oral health, responding to COVID-19, and addressing health inequities and disparities.

Delta Dental companies served communities' oral health by supporting direct dental treatment in underserved communities; water fluoridation initiatives; and oral health education.

Delta Dental companies responded to COVID-19 by delivering loans to safety net dental clinics; enabling dental offices to acquire PPE; and supporting local safety nets like food banks.

Delta Dental companies reacted to the country's struggle with its long history of racial injustice by investing in organizations like the NAACP and the National Urban League; reaching underserved communities of color with oral health programs; and supporting scholarships and training for dentists of color.

"Community is everything to us at Delta Dental,” said Vivian Vasallo, Executive Director, Delta Dental Institute. “While the memories of 2020 will stay with us for years to come, so will the positive impact the Delta Dental companies had on millions of lives by keeping our promise to serve the oral and overall health of our communities.”

Delta Dental's 2020 Community Impact Report features a digital story component with an interactive map showcasing the Delta Dental companies' and foundations' community impact work in all 50 states, Washington, D.C., and Puerto Rico.

The full report is available online at 2020cir.deltadental.com.

About Delta Dental Plans Association

Based in Oak Brook, Illinois, Delta Dental Plans Association is the not-for-profit national association of the 39 independent Delta Dental companies. Through these companies, Delta Dental is the nation's largest dental insurance provider, covering more than 80 million Americans and offering the country's largest dental network with approximately 153,000 participating dentists. Over the last decade, Delta Dental companies provided over $1.75 billion in direct and in-kind support to improve the oral health of our communities across the country.

About the Delta Dental Institute

The Delta Dental Institute is dedicated to advancing oral health for all Americans in partnership with the Delta Dental companies and dedicated partners across the country. With expertise rooted in Delta Dental's rich history of oral health leadership, we engage in and support oral health research, community outreach, and advocacy, striving to ensure everyone understands the importance of oral health to overall health and has access to the care that they need.

The American Dental Association (ADA) is pleased dental practices are largely exempt from the new emergency temporary standard (ETS) for COVID-19 issued for health care settings by the Occupational Safety and Health Administration (OSHA).

“This new infection control guidance and very low COVID-19 infection rate for dentists and dental hygienists prove that dental practices are safe workplaces,” states ADA President Daniel J. Klemmedson, D.D.S., M.D.

The new OSHA workplace ETS provides guidance to be implemented in health care settings where all employees may not be screened for COVID-19, and non-employees and patients with suspected or confirmed COVID-19 are allowed to enter and may be treated. Dental offices most likely to be affected by this standard would include hospital-based oral surgery practices or those who provide care for COVID-19 patients.

Dental offices should have a written COVID-19 plan in place. If an office is covered under this ETS it is mandated to do so. If an office is exempt, it still should do a hazard assessment and written plan as recommended in OSHA’s Recommended Practices for Safety and Health Programs. Based on OSHA’s Hazard Identification and Assessment, the ADA has already created a guide and checklist to walk dentists through this process at ADA.org/virus.

According to OSHA’s recommendations, dentists should continue pre-appointment patient screenings to identify individuals with suspected or confirmed COVID-19, rescheduling their appointments if possible or referring them as necessary.

As the pandemic restrictions across the country are reviewed at the federal, state and local government levels, the safety of patients, dentists and dental team members will remain ADA’s utmost concern. The ADA notes that per the OSHA guidelines, employers are encouraged to follow Centers for Disease Control and Prevention (CDC), state and local regulatory guidelines.

Editor’s Note: Reporters are invited to follow the ADA on Twitter @AmerDentalAssn

About the ADA

The not-for-profit ADA is the nation's largest dental association, representing 163,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance long has been a valuable and respected guide to consumer dental care products. The monthly The Journal of the American Dental Association (JADA) is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit ADA.org. For more information on oral health, including prevention, care and treatment of dental disease, visit the ADA's consumer website MouthHealthy.org

Sunbit has launched a buy now, pay later solution made specifically for dental practices. Many practices are selecting Sunbit as the primary buy now, pay later (BNPL) partner of choice, with its ability to serve 85% of patients who apply. Sunbit's BNPL program, made for dental, offers access to financing for procedures between $60 and $10,000, with 6, 12, 18 and 24 month payment plan options. All qualified patients get access to 0% for 6- or 12-month payment plans. Sunbit powers the application process and manages the collections process. The dental office gets paid right away, contributing directly to the cash flow of the business without the risk of a patient defaulting on the loan.

"We are committed to improving our patients' lives by offering them the best possible dental care by providing access to financing options that are fair and accessible to nearly everyone," said Dr. David Ting, Founder of BDG Dental. "The paperless application is incredibly easy, and we've already seen a 151% increase in patient approval rates and nearly $1 million incremental sales in the first 8-months with Sunbit technology."

"Sunbit's technology has improved our productivity, and most importantly, our patient experience," said Tim Tursonoff, CEO of ALFA Dental Management. "No other tool increases speed and effectiveness of the patient financing process, making it a closing tool instead of a pain point for our patients -- eliminating disappointing declines, scrambling for financing alternatives, unnecessary treatment delays -- and applying doesn't even affect the patient's credit. Our patients have better outcomes by being able to get the treatments they need, and we get paid right away. We have built our business on the ability to deliver same-day, quality comprehensive dentistry to our patients since 2005. Sunbit has been instrumental in helping us deliver this type of treatment to as many patients as possible as soon as possible, 7 days a week. It's a true win-win."

In addition to its focus on patient experience, Sunbit is also practice-focused, providing tools and support to ensure successful implementation. The platform offers near real-time reporting so that practice owners, office managers, and treatment coordinators can review their performance at the coordinator, office, or dental service organization level. This includes the number of applications, approval rate, and production earned from Sunbit's technology. Dental practices are assigned a dedicated success team to ensure that office managers and treatment coordinators are trained, certified and continually engaged so they can confidently take full advantage of Sunbit technology.

Click here for information on how to implement Sunbit technology at your practice.

About Sunbit:

Sunbit is the preferred buy now, pay later technology for everyday needs and services. Sunbit eases the stress of buying everyday things by offering access to fast, fair and transparent payment options to people everywhere. Our technology is offered in-store and online at 7,300 locations, including 1 in 4 auto dealership service centers, optical practices, dentist offices and specialty healthcare services. All loans are made by Transportation Alliance Bank, Inc., dba TAB Bank, which determines qualifications for and terms of credit.

MouthWatch, LLC a leader in innovative teledentistry solutions, digital case presentation tools and intraoral imaging devices, recently named Sylvia Rochon as its Senior Director of Sales and Marketing.

In this newly created executive role, Rochon will have a wide range of strategic and tactical responsibilities focused on the ultimate goal of growing the MouthWatch business across all product lines and distribution channels in order to meet its aggressive financial goals. Some of Rochon’s specific areas of responsibility include:

• Mentor sales and marketing team members.

• Lead cross-functional teams to develop and design new programs and initiatives.

• Establish and monitor performance metrics for the company’s marketing and sales teams.

• Direct the company’s business development efforts.

• Represent MouthWatch as a public-facing advocate for the company and its multiple product lines.

According to MouthWatch CEO and Founder Brant Herman, “Sylvia is uniquely qualified to help MouthWatch clarify its message, synergize its sales and marketing teams, and be a catalyst for accelerated growth. We are all fortunate to be working with her.”

A resident of Montreal, Quebec, Rochon holds an MBA from Harvard Business School and has more than 25 years of senior sales and marketing management experience with innovative dental companies including Air Techniques and Dentsply Sirona. She recently published several dental journal articles on the benefits of teledentistry.

"I'm very happy to join such an innovative team,” said Rochon. “MouthWatch has been promoting teledentistry before it was on people's minds and has disrupted the intraoral market with its affordable, high-quality camera. I look forward to achieving our common goals and meeting our customers in person or through our TeleDent platform!"

About MouthWatch, LLC:

Headquartered in Metuchen, New Jersey, MouthWatch, LLC is a leader in innovative teledentistry solutions, digital case presentation tools and intraoral imaging devices. The company is dedicated to finding new ways to constantly improve the dental health experience for both patient and provider.

In 2020, MouthWatch was ranked #1303 in the 2020 Inc. 5000 list of the Fastest Growing Privately Held Companies. In addition, the company earned the following dental industry awards: The 2020 Cellerant Best of Class Award for TeleDent™, the provider-focused, patient-friendly teledentistry platform. TeleDent™ also won Dentistry Today Magazine’s 2020 Top Innovative Products Award.

What’s more, the MouthWatch Intraoral Camera won the Dentaltown Magazine’s 2020 Dental Townie Choice Award™ as well as Dentistry Today Magazine’s Top 100 Products Award. For more information about MouthWatch, LLC and its innovative products, visit www.MouthWatch.com. 

Keystone Industries and Carbon are pleased to announce the validation of Keystone’s KeyGuide® 3D resin for printing dental surgical guides in the Carbon® M-series printer workflow.

KeyGuide is an extremely strong Class I medical device resin that is ideal for fabricating transparent surgical guides, allowing doctors to stably place implants at a precise angle and depth. KeyGuide is manufactured in New Jersey, USA, has 3 years of guaranteed shelf life, and is available for sale in the USA, Canada, Europe, Australia, and other global territories.

The outstanding quality of KeyGuide paired with the efficient, high-quality, high-speed production of the Carbon 3D printing platform is an optimal combination for dental laboratories. With the explosion of dental implant options in the industry, the use of 3D printed surgical guides for implant planning and placement has grown exponentially—a recent study by the National Association of Dental Laboratories showed that surgical guides are among the most printed dental devices today. KeyGuide’s extreme strength and accuracy are a perfect fit for surgical guides that need to withstand the forces of drilling during surgery while remaining stable and accurate for the best patient results. Carbon users can print dozens of devices quickly and efficiently with no concerns about the quality of the printed part.

“We are really pleased to add another validated KeyPrint medical device resin to the Carbon platform,” noted Keystone Industries dental president, Ira Rosenau. “Carbon and its subscribers have been wonderful partners to Keystone since we launched KeySplint Soft Clear in 2019, including through the recent additions of both KeySplint Hard and KeyGuide to the Carbon offerings. We hope to continue to work closely with the outstanding professionals at Carbon to deliver quality and value to the subscribers with top-end products like KeyGuide.”

Carbon’s breakthroughs in oral health are powered by Carbon Digital Light Synthesis™ (Carbon DLS™) technology, which uses light and oxygen to rapidly produce high-quality, end-use products from a pool of liquid resin. Carbon’s innovations in software, hardware, and material science provide a platform for dental labs to produce next-generation, bespoke oral devices. The Carbon platform significantly improves accuracy and efficiency while reducing time to design and manufacture.

The Carbon 3D printing platform enables laboratories to print and post process approximately eight surgical guides in under 2 hours, more than four times the typical throughput of milling processes, with a material cost per guide under $3 compared to expensive milling materials. “We’re excited we can now make the KeyGuide available to Carbon’s global network of dental partners and customers via the Carbon 3D printing platform,” said Todd Ames, Vice President of Carbon’s Oral Health Business. “We believe the KeyGuide resin will enable Carbon partner labs to provide the highest quality surgical guides with an extremely high ROI.”

Keystone has been a trusted dental manufacturer since 1908 and has developed an expertise over several decades in manufacturing photopolymer formulations. The KeyPrint® dental 3D printing solutions are manufactured in the USA and stocked in Keystone’s US and EU fulfilment centers. For more information about KeySplint Soft® and the entire KeyPrint line of 3D printing resins, please visit https://keyprint.keystoneindustries.com/.

Many of the common procedures carried out by dentists have very low risk of increasing the aerosol spread of COVID-19 and some procedures, such as ultrasonic scaling, were not shown to generate aerosol other than from the clean instrument itself, new research has found.

The National Institute for Health Research (NIHR) and UK Research and Innovation(UKRI)-funded study by the University of Bristol, University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) and North Bristol NHS Trust (NBT) is the largest to date to specifically measure aerosol generation from dental instruments in real-patient clinical scenarios. The paper is published on the preprint server medRxiv.

COVID-19 has required additional precautions in dental practices to protect patients and staff, including the use of FFP3 masks and extra time between patients to allow aerosol to disperse. These measures only apply to dental aerosol generating procedures and have led to a dramatic reduction in dental services. Several studies have already demonstrated that aerosols are produced in simulated studies on dental dummies. However, it is not clear which dental procedures generate aerosol and, if they do, whether the aerosol could potentially carry the SARS-CoV-2 virus.

The research, part of the AERosolisation And Transmission Of SARS-CoV-2 in Healthcare Settings (AERATOR) study, set out to measure the amount of aerosol produced from a wide range of dental procedures carried out on patients. Where aerosol was detected in patient procedures, the research team compared the size distributions of this aerosol to the aerosol produced from the dental instrument itself when used in a (non-patient) phantom head control.

The study found the ultrasonic instrument, commonly used for dental scaling, produced much lower aerosol concentrations than the high-speed dental drill despite the two instruments currently requiring the same precautions. Also, aerosol produced during the ultrasonic scaling procedure was consistent with the clean aerosol produced from the instrument itself and did not show additional aerosol is produced that could potentially spread COVID-19.

Tom Dudding, Restorative Dentistry Specialty Trainee in the Bristol Dental School at the University of Bristol and joint first author of the study, said: “Our study confirms much of the guidance around dental procedures deemed as low risk of spreading COVID-19 is correct, but suggests that the ultrasonic instrument could be seen as lower risk than it currently is.

“Our findings could allow the expansion of dental, hygiene and therapy work as it would reduce the need for additional precautions such as additional personal protective equipment (PPE) and fallow times when using this instrument.”

Mark Gormley, Consultant Senior Lecturer in the Bristol Dental School and joint senior author of the study, added: “Our study provides strong evidence to confirm many of the common dental procedures have very low risk of increasing the aerosol spread of COVID-19. We also found that some other procedures, such as ultrasonic scaling, do not appear to generate additional aerosol above that of the instrument itself and do not increase the risk to dentists, relative to the risk of being near the patient.”

For procedures such as the high- and slow- speed drilling commonly used for dental fillings, crown preparations and polishing, the next step for the research team would be to repeat these experiments with instruments which can further differentiate between aerosol produced by the dental instrument and aerosol which has been contaminated by bodily fluids, such as saliva. If no contaminated aerosol is identified, these instruments would also be safe for use without additional precautions.

The researchers will also consider conducting a non-inferiority, randomised controlled trial of additional precautions (PPE and fallow time) versus pre-COVID-19 precautions in dental practices. The study would look at the difference in infection rates in patients and dental staff across the two groups with no difference demonstrating the additional precautions are not needed.

Paper: ‘A clinical observational analysis of aerosol emissions from dental procedures’ by T. Dudding, S. Sheikh, M Gormley , AERATOR group et al in medRxiv

Please note this is a preprint, it is a preliminary piece of research that has not yet been through peer review and has not been published in a scientific journal – so this is early data

In a clearly distinctive move to make perfect smiles easy and accessible, Aspen Dental Management Inc. (ADMI) launches Motto, a new, clear aligner experience that does not force patients to choose between quality, affordability, convenience and expertise.

Motto, the industry’s top clear aligner, is exclusively available at 900 independently owned Aspen Dental locations in 43 states.

At a time when seven out of 10 patients would benefit from orthodontic treatment, and with more than 30,000 patients visiting the Aspen Dental network daily, Motto is an industry disruptor that will fill a large gap that exists where patients must choose between expensive products or DIY at-home treatments that lack dental guidance. Motto is so much more than a product; it is a doctor-led experience unlike any other in the industry.

Aspen Dental doctors guide patients at every step, starting with a precision digital scan used to custom-craft each and every aligner. Onsite labs and advanced, in-office technology allow patients to leave with their “tray one on day one,” rather than waiting weeks for their aligners or impression kit.

Aspen Dental is the only healthcare provider that has the network to provide this level of care nationally. It delivers on their doctors’ bold call to anyone seeking improved oral health and confidence: Stop waiting and start smiling.

“Our approach at Aspen Dental has always been about providing access to care and saying ‘yes’ when others in the dental space say ‘no’,” says Bob Fontana, Chairman and CEO of ADMI. “Making aligners affordable and convenient for patients while having a doctor with you every step of the way truly differentiates the experience for patients.”

ADMI is a national healthcare leader known for accessible, patient-guided care. With a vision to enhance and expand healthcare services to anybody, anywhere, Aspen Dental is fueled by the expertise and capabilities of a vast network of doctors nationwide. Motto further expands ADMI’s comprehensive portfolio of consumer-focused, professionally-backed dental solutions that serve the $49 billion personal oral care and $400 billion global dental healthcare markets.

“Our sheer scale allows us to provide the highest quality aligners at an unbeatable price,” says Sarah Sharfstein, Vice President of Category Development & Strategy at ADMI. “We are removing friction from the system, making delivery of clear aligners easy for the doctors we support. And for patients, the entire experience is virtually hassle-free, with walk-in appointments and extended hours available, plus technology that truly delivers same-day start capability and reduces the number of visits to the offices.”

“As masks go off and smiles go on, Motto is here,” says Ash ElDifrawi, Chief Marketing and Customer Experience Officer at ADMI. “We are seeing an increased demand from patients who want to improve their smiles. This is definitely a wake-up call that perfect smiles are not just for a chosen few — they are for anyone, anywhere, who is looking for a new beginning.”

Motto is now available at Aspen Dental offices across the U.S. Plans starting at $1,999, dentist included, with zero-down and 100% approval options. For more information, visit AspenDental.com / MottoAligners.com.

It is a fantastic time to join the Aspen Dental team. Check out career opportunities at https://www.aspendentaljobs.com.

About Aspen Dental Management Incorporated (ADMI)

Aspen Dental Management, Inc. (ADMI) is one of the largest and most trusted retail healthcare business support organizations in the U.S., supporting 15,000 healthcare professionals and team members at more than 1,000 health and wellness offices across 46 states in three distinct categories: Dental care, urgent care, and medical aesthetics. Working in partnership with independent practice owners and clinicians, the team is united by a single purpose: to prove that healthcare can be better and smarter for everyone. ADMI provides a comprehensive suite of centralized business support services that power the impact of four consumer-facing businesses: Aspen Dental, ClearChoice Dental Implant Centers, WellNow Urgent Care and Chapter Aesthetic Studio. Each brand has access to a deep community of experts, tools and resources to grow their practices, and an unwavering commitment to delivering high-quality consumer healthcare experiences at scale.

About Aspen Dental

The Aspen Dental network includes 900 offices, in 43 states, owned and operated by independent practice owners and dentists, who operate with clinical autonomy and share a commitment to creating access to care for those who need it most. These independent practice owners expect to record six million patient visits in 2021, driven by a commitment to breaking down barriers to quality, affordable oral health care. Each dental care team offers patients a safe, welcoming, judgment-free environment to address their dental challenges, including comprehensive exams, cleanings, extractions, fillings, periodontal treatment, whitening, oral surgery, crown and bridge work, and denture services. https://www.aspendental.com/

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it has acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a leading and fast-growing virtual dental billing outsourcing service that will advance the Company's mission to offer best-of-breed solutions to help dental practices operate more efficiently and profitably, freeing up practice resources to focus on patient care.

Headquartered in American Fork, UT, eAssist was founded in 2011 by James Anderson, DMD, and Sandy Odle to assist with billing challenges in his dental practices. Dr. Anderson will continue to manage the eAssist business as Chief Executive Officer, along with the current eAssist management team. In 2020, eAssist had sales of approximately $31 million. Henry Schein expects that eAssist will be slightly dilutive to the Company’s 2021 financial results and to be accretive thereafter. Financial terms were not disclosed.

“Henry Schein has a long-standing commitment to supporting dental practice growth, efficiency, and profitability through our comprehensive offering of solutions,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “We are delighted to add eAssist to our leading portfolio of value-added services, which will help our customers improve their critical insurance and billing functions so dental teams can focus on delivering quality patient care. We welcome our new colleagues to Team Schein and look forward to continued success together.”

eAssist uses a combination of technology and human expertise to provide outsourced insurance billing services to dental practices, helping practices to free-up resources to focus on patient care and clinical outcomes. By enhancing collections processes, eAssist allows dental practices to simplify operations and reduce stress related to cashflow.

“By addressing the important topic of collections, we not only expand our value-added services, but also strengthen our relationship as a trusted advisor to our customers,” said Jonathan Koch, Senior Vice President and CEO, Henry Schein Global Dental Group. “eAssist will help practices enhance cash flow from timely collections and more accurate claims submissions and processing.”

eAssist is currently designed to support dental practices of all sizes through technology supported by a network of dental billing professionals. In addition to its core dental billing service, newer offerings from eAssist include securing detailed patient eligibility information, billing certain dental procedures through medical insurance, and practice bookkeeping.

“Henry Schein represents an exceptional and complementary cultural fit as a partner for eAssist,” said Dr. Anderson. “Through new and powerful sales, marketing, and technology resources, we expect to bring the myriad of benefits from eAssist’s technology-powered service offerings to many more dental practices. Henry Schein has a clear commitment to advancing dental practice efficiency and profitability, and we believe they are the right partner to help us help even more dentists succeed.”

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 20,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company's sales from continuing operations reached $10.1 billion in 2020, and have grown at a compound annual rate of approximately 12 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

About eAssist Dental Solutions

eAssist Dental Solutions is the nation’s leading provider of remote dental billing and patient billing services for dental offices. The more than 1,200 eAssist team members serve over 2,000 dental practices through proprietary technology platforms that enhance a dental practice’s revenue cycle management. The company’s end-to-end solution eases the burden on office staff, ultimately helping practices be more efficient, profitable and patient-focused.

To learn more, visit eAssist online at: www.dentalbilling.com, Facebook.com/eAssistMe, and @eAssist.me on Instagram.

Cautionary Note Regarding Forward-Looking Statements

In accordance with the “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995, we provide the following cautionary remarks regarding important factors that, among others, could cause future results to differ materially from the forward-looking statements, expectations and assumptions expressed or implied herein. All forward-looking statements made by us are subject to risks and uncertainties and are not guarantees of future performance. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, and achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These statements are generally identified by the use of such terms as “may,” “could,” “expect,” “intend,” “believe,” “plan,” “estimate,” “forecast,” “project,” “anticipate,” “to be,” “to make,” or other comparable terms. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the documents we file with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K. Forward looking statements include the overall impact of the Novel Coronavirus Disease 2019 (COVID-19) on the Company, its results of operations, liquidity, and financial condition (including any estimates of the impact on these items), the rate and consistency with which dental and other practices resume or maintain normal operations in the United States and internationally, expectations regarding personal protective equipment (“PPE”) and COVID-19 related product sales and inventory levels and whether additional resurgences of the virus will adversely impact the resumption of normal operations, the impact of restructuring programs as well as of any announced and future acquisitions, and more generally current expectations regarding performance in current and future periods. Forward looking statements also include the (i) ability of the Company to make additional testing available, the nature of those tests and the number of tests intended to be made available and the timing for availability, the nature of the target market, as well as the efficacy or relative efficacy of the test results given that the test efficacy has not been, or will not have been, independently verified under normal FDA procedures and (ii) potential for the Company to distribute the COVID-19 vaccines and ancillary supplies.

Risk factors and uncertainties that could cause actual results to differ materially from current and historical results include, but are not limited to: risks associated with COVID-19, as well as other disease outbreaks, epidemics, pandemics, or similar wide spread public health concerns and other natural disasters or acts of terrorism; our dependence on third parties for the manufacture and supply of our products; our ability to develop or acquire and maintain and protect new products (particularly technology products) and technologies that achieve market acceptance with acceptable margins; transitional challenges associated with acquisitions, dispositions and joint ventures, including the failure to achieve anticipated synergies/benefits; financial and tax risks associated with acquisitions, dispositions and joint ventures; certain provisions in our governing documents that may discourage third-party acquisitions of us; effects of a highly competitive (including, without limitation, competition from third-party online commerce sites) and consolidating market; the potential repeal or judicial prohibition on implementation of the Affordable Care Act; changes in the health care industry; risks from expansion of customer purchasing power and multi-tiered costing structures; increases in shipping costs for our products or other service issues with our third-party shippers; general global macro-economic and political conditions, including international trade agreements and potential trade barriers; failure to comply with existing and future regulatory requirements; risks associated with the EU Medical Device Regulation; failure to comply with laws and regulations relating to health care fraud or other laws and regulations; failure to comply with laws and regulations relating to the confidentiality of sensitive personal information or standards in electronic health records or transmissions; changes in tax legislation; litigation risks; new or unanticipated litigation developments and the status of litigation matters; cyberattacks or other privacy or data security breaches; risks associated with our global operations; our dependence on our senior management, as well as employee hiring and retention; and disruptions in financial markets. The order in which these factors appear should not be construed to indicate their relative importance or priority.

We caution that these factors may not be exhaustive and that many of these factors are beyond our ability to control or predict. Accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results. We undertake no duty and have no obligation to update forward-looking statements.

Komet USA today announced the availability of a new endodontic motor, EndoPilot. The EndoPilot is a powerful, torque and speed controlled endodontic motor with state-of-the-art technology that can help endodontists and general practitioners complete endodontic procedures more efficiently while ensuring patient safety.

Dr. Chris Cook, an endodontist in Louisville, Kentucky said, “I can honestly say the EndoPilot has become a part of my day that has changed the way I practice. I won’t work without it, and I know others will feel the same as soon as they have a chance to try it!”

The EndoPilot has several innovative features, including a motor function that stops once the preparation length has been reached and an integrated apex locator that shows the precise file position in real-time. It also allows for customizable preparation length at the apex locator and prevents chip compaction by reducing torque in the vicinity of the apex.

It comes with a fully insulated handpiece that optimizes apex location in endodontic procedures, a 7-inch touchscreen to easily set the depth of preparation relative to the apex and a wireless foot pedal rheostat to eliminate cords, further improving ergonomics and portability.

Todd Blanton, CEO of Komet USA noted, “Komet USA has become known for our high-quality products and focus on dental rotary innovation. The introduction of the EndoPilot is the latest example of our commitment to helping our dental customers to provide improvements in patient care.”

The EndoPilot also features the ReFlex motion, a patented, counterclockwise, intelligent movement. The ReFlex motion starts with an efficient left-cutting rotary motion and then transitions to a reciprocating motion when the EndoPilot senses resistance. This decreasing torsional stress on the file, prevents file jamming and minimizes the risk of file separation.

The ReFlex motion is exclusively available with Komet USA’s Procodile file system on the EndoPilot.

The EndoPilot has a pre-loaded file library containing a number of popular file systems and a rechargeable battery that supports 15 hours of continuous operation.

With the new endo motor, Komet USA can now provide endodontists and general practitioners with a treatment system that incorporates innovative technology to perform endodontic procedures safely and effectively. Every product in the Komet endodontic portfolio has been meticulously researched, designed and tested in Komet’s state-of-the-art German facility.

The products are now available to buy online at www.kometusa.com or through a local Komet USA sales representative. You can also request a demo of the EndoPilot.